Trial · NCT04273139
Adverse events132
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 132
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Ibrutinib and Venetoclax | 8 | 45 | 8 |
| other | Easy bleeding | Blood and lymphatic system disorders | Ibrutinib and Venetoclax | 6 | 45 | 6 |
| other | Petechia | Blood and lymphatic system disorders | Ibrutinib and Venetoclax | 1 | 45 | 1 |
| other | Atrial Fibrillation | Cardiac disorders | Ibrutinib and Venetoclax | 3 | 45 | 3 |
| other | Chest pain | Cardiac disorders | Ibrutinib and Venetoclax | 3 | 45 | 3 |
| other | Palpitations | Cardiac disorders | Ibrutinib and Venetoclax | 9 | 45 | 9 |
| other | Blurred vision | Eye disorders | Ibrutinib and Venetoclax | 1 | 45 | 1 |
| other | Dry eye | Eye disorders | Ibrutinib and Venetoclax | 1 | 45 | 1 |
| other | Eye pain | Eye disorders | Ibrutinib and Venetoclax | 2 | 45 | 2 |
| other | Floaters | Eye disorders | Ibrutinib and Venetoclax | 1 | 45 | 1 |
| other | Retinal vein occlusion | Eye disorders | Ibrutinib and Venetoclax | 1 | 45 | 1 |
| other | Abdominal pain | Gastrointestinal disorders | Ibrutinib and Venetoclax | 4 | 45 | 4 |
| other | Bloating | Gastrointestinal disorders | Ibrutinib and Venetoclax | 3 | 45 | 3 |
| other | Constipation | Gastrointestinal disorders | Ibrutinib and Venetoclax | 8 | 45 | 8 |
| other | Diarrhea | Gastrointestinal disorders | Ibrutinib and Venetoclax | 26 | 45 | 26 |
| other | Dry mouth | Gastrointestinal disorders | Ibrutinib and Venetoclax | 2 | 45 | 2 |
| other | Dyspepsia | Gastrointestinal disorders | Ibrutinib and Venetoclax | 2 | 45 | 2 |
| other | Dysphagia | Gastrointestinal disorders | Ibrutinib and Venetoclax | 1 | 45 | 1 |
| other | C. difficile infection | Gastrointestinal disorders | Ibrutinib and Venetoclax | 1 | 45 | 1 |
| other | Flatulence | Gastrointestinal disorders | Ibrutinib and Venetoclax | 7 | 45 | 7 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04273139/events